| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 18, 2025 | Buy(P) | 10K | $0.63 | $6K | 818K |
| Mar 14, 2025 | Buy(P) | 26K | $0.63 | $16K | 808K |
| Mar 13, 2025 | Buy(P) | 34 | $0.64 | $22 | 783K |
| Mar 12, 2025 | Buy(P) | 12K | $0.62 | $7K | 783K |
| Mar 11, 2025 | Buy(P) | 2K | $0.58 | $1K | 771K |
| Mar 10, 2025 | Buy(P) | 15K | $0.58 | $8K | 769K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001398344-25-007141) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NovaBay Pharmaceuticals, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001398344-25-007141"
Use Arkolith to summarize insider buying and selling at NovaBay Pharmaceuticals, Inc. over the last 90 days and cite the filings.